eMedicine Specialties > Vascular Surgery > Medical Topics

Chronic Venous Insufficiency

Author: Katherine E Brown, DO, Consulting Staff, Department of Surgery, University of California at San Diego
Contributor Information and Disclosures

Updated: May 11, 2009

Introduction

Chronic venous insufficiency (CVI) is a common condition affecting 2-5% of Americans. Historically, CVI was known as postphlebitic syndrome and postthrombotic syndrome, both of which refer to the etiology of most cases. However, these names have been abandoned because they fail to recognize another common cause of the disease, the congenital absence of venous valves.

Picture of venous valve: Thrombosis can begin as ...

Picture of venous valve: Thrombosis can begin as blood flow becomes turbulent, permitting platelets to remain in the valve sinus. This forms the nidus of a thrombus.

Picture of venous valve: Thrombosis can begin as ...

Picture of venous valve: Thrombosis can begin as blood flow becomes turbulent, permitting platelets to remain in the valve sinus. This forms the nidus of a thrombus.


History of the Procedure

In 1914, Homans postulated that the relative hypoxia of static venous blood decreases the amount of oxygen reaching the skin, causing skin changes and ulcers characteristic of CVI.1

In 1930, Landis et al demonstrated the direct relationship between venous hypertension in the legs and increased capillary intraluminal pressures.

In 1953, Piulacks et al theorized that arteriovenous fistulas in the skin of the lower extremities cause hypoxia, resulting in changes to the skin and tissues.2

In 1982, Burnand et al presented the fibrin cuff hypothesis, which describes the primary problem as venous hypertension in the lower extremities causing leakage of plasma proteins, particularly fibrinogen.3 A fibrin cuff encircles affected capillaries, decreasing oxygen diffusion to surrounding tissues.

In 1988, Coleridge-Smith et al described the white-cell trapping theory, which hypothesizes that venous hypertension and resultant increased capillary pressures trap white blood cells in the capillaries, where they become activated and damage capillary beds.4 Increased capillary permeability allows seepage of plasma proteins and fibrinogen into the interstitium, where a fibrin cuff forms, thus decreasing oxygen diffusion to surrounding tissues.

Problem

In addition to poor cosmesis, CVI can lead to chronic life-threatening infections of the lower extremities. Pain, especially after ambulating, is a hallmark of the disease. CVI causes characteristic changes, called lipodermatosclerosis, to the skin of the lower extremities, which lead to eventual skin ulceration.5

Frequency

CVI is a significant public health problem in the United States. Of all Americans, estimates indicate that 2-5% have some changes associated with CVI.

Approximately 24 million Americans have varicose veins. Approximately 6 million Americans have skin changes associated with CVI. Venous stasis ulcers affect approximately 500,000 people.

The mean incidence for hospital admission for CVI is 92 per 100,000 admissions.

Epidemiology:

Peak incidence occurs in women aged 40-49 years and in men aged 70-79 years.

Etiology

Congenital absence of or damage to venous valves in the superficial and communicating systems can cause CVI. Venous incompetence due to thrombi and formation of thrombi favored by the Virchow triad (venous stasis, hypercoagulability, endothelial trauma6 ) also can cause CVI (see Image 1).  Varicose veins rarely are associated with the development of CVI.

Picture of venous valve: Thrombosis can begin as ...

Picture of venous valve: Thrombosis can begin as blood flow becomes turbulent, permitting platelets to remain in the valve sinus. This forms the nidus of a thrombus.

Picture of venous valve: Thrombosis can begin as ...

Picture of venous valve: Thrombosis can begin as blood flow becomes turbulent, permitting platelets to remain in the valve sinus. This forms the nidus of a thrombus.


Risk factors associated with chronic venous insufficiency
  • Age: Incidence of CVI rises substantially with age.
  • Family history: History of deep vein thrombosis (DVT), which renders venous valves incompetent, causing backflow and increased venous pressure, is a risk factor.
  • Lifestyle: A sedentary lifestyle minimizes the pump action of calf muscles on venous return, causing higher venous pressure. CVI occurs more frequently in women who are obese. Vocations that involve standing for long periods predispose individuals to increased venous pressure in dependent lower extremities. A higher incidence of CVI is observed in men who smoke.

Pathophysiology

Two major mechanisms in the body prevent venous hypertension. First, bicuspid valves in the veins prevent backflow and venous pooling. DVTs commonly occur at these valves, causing irreversible damage to the valve. Second, during normal ambulation, calf muscles decrease venous pressures by approximately 70% in the lower extremities. With rest, pressures return to normal in approximately 30 seconds. In diseased veins, ambulation decreases venous pressures by only 20%. When ambulation is stopped, pressure in the vein lumen increases slowly, returning to normal over a period of minutes (see Image 2).


Hemodynamic charting of (a) healthy patients, (b)...

Hemodynamic charting of (a) healthy patients, (b) patients with only varicose veins, (c) patients with incompetent perforator veins, and (d) patients with deep and perforator incompetence.

Hemodynamic charting of (a) healthy patients, (b)...

Hemodynamic charting of (a) healthy patients, (b) patients with only varicose veins, (c) patients with incompetent perforator veins, and (d) patients with deep and perforator incompetence.


Venous hypertension in diseased veins is thought to cause CVI by the following sequence of events. Increased venous pressure transcends the venules to the capillaries, impeding flow. Low-flow states within the capillaries cause leukocyte trapping. Trapped leukocytes release proteolytic enzymes and oxygen free radicals, which damage capillary basement membranes. Plasma proteins, such as fibrinogen, leak into the surrounding tissues, forming a fibrin cuff. Interstitial fibrin and resultant edema decrease oxygen delivery to the tissues, resulting in local hypoxia. Inflammation and tissue loss result.

Presentation

Clinical manifestations include the following:7

  • Varicose veins: In addition to poor cosmesis, varicose veins serve as indicators of venous hypertension, the most common reason for patient complaints regarding CVI (see Image 1).8
Picture of venous valve: Thrombosis can begin as ...

Picture of venous valve: Thrombosis can begin as blood flow becomes turbulent, permitting platelets to remain in the valve sinus. This forms the nidus of a thrombus.

Picture of venous valve: Thrombosis can begin as ...

Picture of venous valve: Thrombosis can begin as blood flow becomes turbulent, permitting platelets to remain in the valve sinus. This forms the nidus of a thrombus.

  • Leg discomfort: Venous hypertension in muscles and fascial compartments of the lower leg from exercise and prolonged standing results in the characteristic ache of CVI. The discomfort is described as pain, pressure, burning, itching, dull ache, or heaviness in affected calves or legs.
  • Nonhealing ulcers: Typically, these lesions occur around the medial malleolus, where venous pressure is maximal due to the presence of large perforating veins (see Image 2).5
Hemodynamic charting of (a) healthy patients, (b)...

Hemodynamic charting of (a) healthy patients, (b) patients with only varicose veins, (c) patients with incompetent perforator veins, and (d) patients with deep and perforator incompetence.

Hemodynamic charting of (a) healthy patients, (b)...

Hemodynamic charting of (a) healthy patients, (b) patients with only varicose veins, (c) patients with incompetent perforator veins, and (d) patients with deep and perforator incompetence.

  • Leg edema: Damage done to capillary basement membranes by white blood cells results in leg edema.
  • Lipodermatosclerosis: These characteristic skin changes in the lower extremities include capillary proliferation, fat necrosis, and fibrosis of skin and subcutaneous tissues. Skin becomes reddish or brown because of the deposition of hemosiderin from red blood cells (see Image 3).9
Perforator vein bulging into subcutaneous tissue.

Perforator vein bulging into subcutaneous tissue.

Perforator vein bulging into subcutaneous tissue.

Perforator vein bulging into subcutaneous tissue.


Indications

Surgical treatment is reserved for those with discomfort or ulcers refractory to medical management.

Indications for vein ligation: This technique is reserved for cases of CVI that include reflux in the saphenous system causing severe symptoms.10 For this reason, a diagnosis of reflux must be established preoperatively, usually with photoplethysmography or duplex imaging.

Relevant Anatomy

The venous network in the lower extremities commonly affected by CVI is divided into 3 systems. The first is superficial veins, which include the lesser and greater saphenous veins and their tributaries (see Image 7). The second is deep veins, which include the anterior tibial, posterior tibial, peroneal, popliteal, deep femoral, superficial femoral, and iliac veins. The third is perforating or communicating veins (see Images 8 and 9).

Lower leg venous anatomy.

Lower leg venous anatomy.

Lower leg venous anatomy.

Lower leg venous anatomy.


Perforating veins of the lower leg.

Perforating veins of the lower leg.

Perforating veins of the lower leg.

Perforating veins of the lower leg.


Venogram demonstrating incompetent perforating ve...

Venogram demonstrating incompetent perforating veins.

Venogram demonstrating incompetent perforating ve...

Venogram demonstrating incompetent perforating veins.


Contraindications

In patients with symptomatic greater saphenous varicosities, the presence of an occluded deep system must be ruled out. Deep occlusion is an absolute contraindication to vein ligation. Obtaining venographic studies of the deep venous system prior to superficial vein ligation is imperative.

More on Chronic Venous Insufficiency

Overview: Chronic Venous Insufficiency
Workup: Chronic Venous Insufficiency
Treatment: Chronic Venous Insufficiency
Follow-up: Chronic Venous Insufficiency
Multimedia: Chronic Venous Insufficiency
References
Further Reading

References

  1. Homans J. The etiology and treatment of varicose ulcers of the leg. Surg Gynecol Obstet. 1917;24:300-11.

  2. Piulacks P. Pathogenic study of varicose veins. Angiology. 1953;4:59-100.

  3. Burnand KG, Whimster I, Naidoo A. Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. Br Med J (Clin Res Ed). Oct 16 1982;285(6348):1071-2. [Medline].

  4. Coleridge Smith PD, Thomas P, Scurr JH. Causes of venous ulceration: a new hypothesis. Br Med J (Clin Res Ed). Jun 18 1988;296(6638):1726-7. [Medline].

  5. Renner R, Gebhardt C, Simon JC, Seikowski K. Changes in quality of life for patients with chronic venous insufficiency, present or healed leg ulcers. J Dtsch Dermatol Ges. Apr 6 2009;[Medline].

  6. Carrasco OF, Ranero A, Hong E, Vidrio H. Endothelial Function Impairment in Chronic Venous Insufficiency: Effect of Some Cardiovascular Protectant Agents. Angiology. Feb 23 2009;[Medline].

  7. Morales-Cuenca G, Moreno-Egea A, Aguayo-Albasini JL. [General surgeons and varicose vein surgery.]. Cir Esp. Apr 2009;85(4):205-13. [Medline].

  8. Casian D, Gutsu E, Culiuc V. Surgical treatment of severe chronic venous insufficiency caused by pulsatile varicose veins in a patient with tricuspid regurgitation. Phlebology. 2009;24(2):79-81. [Medline].

  9. Gasparis AP, Tsintzilonis S, Labropoulos N. Extraluminal lipoma with common femoral vein obstruction: a cause of chronic venous insufficiency. J Vasc Surg. Feb 2009;49(2):486-90. [Medline].

  10. Navarro TP, Nunes TA, Ribeiro AL, Castro-Silva M. Is total abolishment of great saphenous reflux in the invasive treatment of superficial chronic venous insufficiency always necessary?. Int Angiol. Feb 2009;28(1):4-11. [Medline].

  11. Vanscheidt W, Ukat A, Partsch H. Dose-response of compression therapy for chronic venous edema--higher pressures are associated with greater volume reduction: two randomized clinical studies. J Vasc Surg. Feb 2009;49(2):395-402, 402.e1. [Medline].

  12. Maksimovic ZV, Maksimovic M, Jadranin D, Kuzmanovic I, Andonovic O. Medicamentous treatment of chronic venous insufficiency using semisynthetic diosmin--a prospective study. Acta Chir Iugosl. 2008;55(4):53-9. [Medline].

  13. Husni EA. Reconstruction of veins: the need for objectivity. J Cardiovasc Surg (Torino). Sep-Oct 1983;24(5):525-8. [Medline].

  14. Raju S, Neglén P. Stents for chronic venous insufficiency: why, where, how and when--a review. J Miss State Med Assoc. Jul 2008;49(7):199-205. [Medline].

  15. Tsai S, Dubovoy A, Wainess R. Severe chronic venous insufficiency: magnitude of the problem and consequences. Ann Vasc Surg. 2005;19:705-11.

  16. Brand FN, Dannenberg AL, Abbott RD. The epidemiology of varicose veins: the Framingham Study. Am J Prev Med. Mar-Apr 1988;4(2):96-101. [Medline].

  17. Elder DM, Greer KE. Venous disease: how to heal and prevent chronic leg ulcers. Geriatrics. Aug 1995;50(8):30-6. [Medline].

  18. Gloviczki P, Bergan JJ, Menawat SS. Safety, feasibility, and early efficacy of subfascial endoscopic perforator surgery: a preliminary report from the North American registry. J Vasc Surg. Jan 1997;25(1):94-105. [Medline].

  19. Ibrahim S, MacPherson DR, Goldhaber SZ. Chronic venous insufficiency: mechanisms and management. Am Heart J. Oct 1996;132(4):856-60. [Medline].

  20. Martinez MJ, Bonfill X, Moreno RM. Phlebotronic for venous insufficiency. Cochrane database of Systematic Reviews. 2005;3.

  21. Neglen P, Raju S. A comparison between descending phlebography and duplex Doppler investigation in the evaluation of reflux in chronic venous insufficiency: a challenge to phlebography as the "gold standard". J Vasc Surg. Nov 1992;16(5):687-93. [Medline].

  22. Nyhus LIM, Barker RB, eds. Mastery of Surgery. 2nd ed. Boston, Mass: Little Brown; 1992:. 2133-9.

  23. Puggioni A, Kalra M, Gloviczki P. Superficial vein surgery and SEPS for chronic venous insufficiency. Seminars Vasc Surg. 2005;18:41-8.

  24. Weiss VJ, Surowiec SM, Lumsden AB. Surgical management of chronic venous insufficiency. Ann Vasc Surg. Sep 1998;12(5):504-8. [Medline].

  25. Wilson SE, Veith FJ, Williams RA. Chronic Venous Insufficiency. Vascular Surgery: Principles and Practice. 1978;723-61.

Further Reading

Clinical guidelines

Leg ulcer guidelines: a pocket guide for practice.
Smith and Nephew, Ltd. - Private For Profit Organization.  2002 (revised 2006 Jan).  39 pages.  NGC:005254

Summary algorithm for venous ulcer care with annotations of available evidence.
Association for the Advancement of Wound Care - Private Nonprofit Organization.  2005.  25 pages.  NGC:004280

Guideline for management of wounds in patients with lower-extremity venous disease.
Wound, Ostomy, and Continence Nurses Society - Professional Association.  2005.  42 pages.  NGC:004431

Clinical trials

Assess the Efficacy and Tolerability of Antistax Film-Coated Tablets in Patients With Chronic Venous Insufficiency

THERMES ET VEINES: Spa for Prevention of Leg Ulcers

A New Method of Surgically Treating Varicose Veins and Venous Ulcers - a Study to Assess Clinical and Economic Value

Related eMedicine topics

Stasis Dermatitis

Deep Venous Thrombosis

Deep Venous Thrombosis and Thrombophlebitis

Varicose Veins

Venous Insufficiency

Keywords

chronic venous insufficiency, CVI, superficial venous insufficiency, venous insufficiency, postphlebitic syndrome, postthrombotic syndrome lipodermatosclerosis, superficial venous incompetence, venous incompetence, valvular incompetence, hypercoagulability, Virchow triad, venous stasis, venous stasis ulcers, venous reflux, stasis dermatitis, stasis ulcer, venous ulcer, DVT, deep vein thrombosis, varicose veins, junctional high-pressure disease, perforator high-pressure disease, venous hypertension, varicosities, varicosity, telangiectasia, venectasia, spider vein, vein disease, venous disease, swollen veins, telangiectatic veins

Contributor Information and Disclosures

Author

Katherine E Brown, DO, Consulting Staff, Department of Surgery, University of California at San Diego
Disclosure: Nothing to disclose.

Medical Editor

William H Pearce, MD, Chief, Division of Vascular Surgery, Violet and Charles Baldwin Professor of Vascular Surgery, Department of Surgery, Northwestern University School of Medicine
William H Pearce, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, American Surgical Association, Association for Academic Surgery, Association of VA Surgeons, Central Surgical Association, New York Academy of Sciences, Society for Vascular Surgery, Society of Critical Care Medicine, Society of University Surgeons, and Western Surgical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Vincent Lopez Rowe, MD, Assistant Professor of Surgery, Department of Surgery, Division of Vascular Surgery, University of Southern California Medical Center
Vincent Lopez Rowe, MD is a member of the following medical societies: American College of Surgeons, Association for Academic Surgery, Peripheral Vascular Surgery Society, Society for Clinical Vascular Surgery, and Society for Vascular Surgery
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

William H Pearce, MD, Chief, Division of Vascular Surgery, Violet and Charles Baldwin Professor of Vascular Surgery, Department of Surgery, Northwestern University School of Medicine
William H Pearce, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, American Surgical Association, Association for Academic Surgery, Association of VA Surgeons, Central Surgical Association, New York Academy of Sciences, Society for Vascular Surgery, Society of Critical Care Medicine, Society of University Surgeons, and Western Surgical Association
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.